Shares of LexaGene Holdings Inc. (CVE:LXG – Get Free Report) dropped 19.2% during trading on Wednesday . The stock traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares traded hands during mid-day trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Price Performance
The company has a debt-to-equity ratio of 138.01, a quick ratio of 1.13 and a current ratio of 1.39. The stock’s 50-day moving average is C$0.11 and its two-hundred day moving average is C$0.11. The stock has a market cap of C$14.77 million, a PE ratio of -1.31 and a beta of 2.26.
LexaGene Company Profile
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Featured Stories
- Five stocks we like better than LexaGene
- High Flyers: 3 Natural Gas Stocks for March 2022
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- The Most Important Warren Buffett Stock for Investors: His Own
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- What to Know About Investing in Penny Stocks
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
